Nicholas Johnson

Virginia delegation at #NOH25

The MDCRN meeting was a success! Thanks to all for working towards treatments for myotonic dystrophy, Charcot Marie tooth disease, facioscapulohumeral muscular dystrophy, and limb girdle muscular dystrophy!

We're hiring! We are excited to be in our new home @VCU in Richmond, VA and are actively recruiting lab members at all levels! If you're interested in basic or translational science in dystrophic muscle 💪 or heart ❤️, contact us!

Learn more about one of MDF's 2024 Research Fellows, Ms. Alexandra Marrero Quinones! Her long-term goal is to identify genetic modifiers of disease severity in #myotonicDystrophy. Learn more at: myotonic.org/research-fello…

Deletion of miR-146a enhances therapeutic protein restoration in model of dystrophin exon skipping ncbi.nlm.nih.gov/pmc/articles/P…

Deletion of miR-146a enhances therapeutic protein restoration in model of dystrophin exon skipping biorxiv.org/content/10.110…

The Splice Index as a prognostic biomarker of strength and function in myotonic dystrophy type 1 biorxiv.org/content/10.110…

CHLA Neuroimmunology expert @Drjonsantoro shares breakthrough discovery in Down Syndrome Regression Disorder with @washingtonpost. chla.org/blog/hospital-…

Myotonic dystrophy is an autosomal dominant form of muscular dystrophy characterized by progressive muscle weakness and wasting. JAMA Insights discusses the signs and symptoms, diagnosis, and treatment of myotonic dystrophy type 1. ja.ma/49Okvav

@aiee_antonio @AANmember @nickjohnson30 @WNGtweets @thgr_neurores @thgr_vasc_neuro Look out 👀💪🧠

You’re never too young to be an advocate for a better healthcare system! #AANadvocacy #NOH24 @AANmember @nickjohnson30 @WNGtweets @thgr_neurores @thgr_vasc_neuro

For more information: curecalpain3.org/trial-readines…

Great MDCRN meeting to advance treatments for myotonic dystrophy, limb girdle muscular dystrophy and facioscapulohumeral muscular dystrophy! @childrensatvcu @VCUNeuro @MyoStrong @CureCalpain3 @FSHDSociety

The CIMR team celebrates Beckers awareness and helps move research forward.

Moving research forward in myotonic dystrophy at CIMR! #internationalmyotonicdystrophyday #myotonicstrong @VCUNeuro

If you or a family member have myotonic dystrophy, the #1 thing you can do to help researchers develop an effective treatment is to enroll in the END-DM1 natural history study. Details here: clinicaltrials.gov/ct2/show/NCT03…

Peter Kang discusses the challenges of genetic diagnosis in lgmd.

GRASP LGMD meeting underway!

Cynthia Gagnon and Guillaume Bassez presenting on the classification of myotonic dystrophy at our dmcrn meeting

Andy Berglund @TheRNAInstitute presenting to the dmcrn on natural products that rescue splicing.